Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMuscle aches are a recognised side effect of tirzepatide (Mounjaro), reported by some people particularly in the early weeks of treatment or after a dose increase. They are typically mild, short-lived, and settle on their own — but knowing what drives them, and when soreness warrants a closer look, helps you make the right call. These medicines are prescription-only, and a GPhC-registered prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the decision most people are quietly trying to make. Muscle aches have several plausible explanations when you are on tirzepatide, and separating them matters before you act. The medicine itself can cause what clinicians call myalgia (generalised muscle discomfort) particularly in the first few weeks or when your dose is stepped up, and if you want a closer look at that specific symptom, our page on Mounjaro muscle ache covers it in more detail. The NHS patient information for tirzepatide lists musculoskeletal pain, including muscle aches, among the side effects people may notice.
At the same time, rapid weight loss itself changes how your body loads and uses muscle. Some people notice soreness that feels more like the aftermath of exercise than a systemic ache. Reduced appetite can also mean lower protein and calorie intake, which affects how well muscles recover. And if nausea or vomiting has been significant, the resulting dehydration contributes its own layer of discomfort. None of these are automatically alarming, but they do point to different responses.
A third, less common possibility is worth knowing about. Rhabdomyolysis (a breakdown of muscle tissue that can strain the kidneys) is a rare but documented concern with several medicines. The signals that should push you toward urgent care are muscle pain that is severe and spreading, accompanied by dark or cola-coloured urine, fever, or marked weakness that develops quickly. If any of those are present, get medical help the same day rather than waiting to see whether things settle.
Timing is genuinely useful here. Aches that arrive within a day or two of a dose increase, feel like general fatigue in the legs or back, and begin to ease after a week or so are the pattern consistent with adjustment-related myalgia. Many people find that staying well hydrated (and not letting nausea push fluid intake down too far) shortens this window considerably.
Aches that persist beyond two to three weeks at a stable dose, or that appear unrelated to any dose change, are worth raising with your prescriber. They may reflect something unconnected to tirzepatide entirely, or they may prompt a slower titration schedule. There is no shame in reporting this kind of thing; adjusting the pace of dose increases is a normal part of prescribing tirzepatide well. If you want to understand the full range of physical discomforts people report, our page on Mounjaro aches sits alongside this one and covers the broader picture. If you have questions about how muscle changes interact with weight loss more broadly, the question of whether Mounjaro affects muscle mass is worth reading alongside this page.
One practical note: if you are starting treatment around a busy stretch (a holiday, a bank holiday, an unusual week) keeping that context in mind when reviewing how you feel is sensible. Tiredness and soreness from travel or disrupted sleep can look a lot like medication side effects on a day-to-day basis.
Some people worry that the aches signal muscle loss, not just temporary discomfort. This is a reasonable concern given that any significant calorie deficit carries a theoretical risk of lean mass reduction, and if that question is on your mind, our dedicated page on whether you lose muscle on Mounjaro addresses the evidence directly. The evidence from the SURMOUNT programme, involving thousands of adults treated with tirzepatide, showed substantial fat mass reduction; preserving lean mass alongside it depends heavily on protein intake and resistance activity, both of which a prescriber or dietitian can help you plan.
Aches alone are not a reliable indicator of muscle loss, they are more often a sign of inflammation, dehydration, or adaptation. If you are specifically concerned about whether tirzepatide is affecting your muscle tissue rather than fat, that question has its own evidence base and is worth addressing directly with your clinical team. The two issues are related but not the same.
For a broader overview of tirzepatide, including how it works and what the licensed schedule looks like, the tirzepatide overview is a useful reference.
Mild, transient muscle aches do not require emergency action, but they do deserve a record. If you are being treated through a regulated service, reporting what you experience is part of how prescribers keep your plan appropriate. At our pharmacy, aftercare is available seven days a week, a question raised on a Sunday morning gets a clinician's response, not an out-of-office. If the aches coincide with other symptoms such as nausea, vomiting, or any of the serious signs described above, contact a prescriber or call NHS 111 rather than waiting for a scheduled review.
Anyone on tirzepatide can also report suspected side effects directly to the MHRA via the Yellow Card scheme, this is separate from your clinical care and helps regulators track how the medicine performs in real-world use. The NHS tirzepatide medicines page sets out the full side-effect profile and includes clear guidance on which symptoms need prompt attention.
If muscle pain is making you question whether treatment is right for you, or you have not yet started and want to understand the side-effect picture before committing, speak to our prescribers, a free consultation is the place to ask exactly these questions.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.